https://www.pharmaceutical-technology.com/data-insights/bimiralisib-torqur-actinic-solar-keratosis-likelihood-of-approval/
Bimiralisib is under clinical development by Torqur and currently in Phase II for Actinic (Solar) Keratosis.
solar keratosisactiniclikelihoodapproval